What is the current management of irritable bowel syndrome in patients with inflammatory bowel disease in remission?
Abstract
Current management of IBS in patients with IBD in remission involves lifestyle and dietary modification, notably with a low FODMAP approach, pharmacotherapy such as rifaximin, and the adjunct use of probiotics, alongside potential psychosocial interventions.
Fields of Study & Subjects
Gastrointestinal motility and disorders
Inflammatory Bowel Disease
Gut microbiota and health
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 3 March 2026
- Language
- EN